Precision medicine

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

New AI technology uses H&E images to create an alternative path for molecular diagnostics

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management

In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues

A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar

An interview with Ruthy Shaco-Levy to explore why in-house laboratory is a valuable resource for both clinicians and patients

Researchers have catalogued almost every NUDT15 variant to understand patients’ likelihood of thiopurine toxicity

Precision medicine is creating a sea change in healthcare and biomedical research. Is your lab prepared for the approaching tsunami of genetic tests?

New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma